Rostrum Medical Appoints New Chief Operating Officer

Vancouver, Canada – With the unanimous endorsement of Rostrum’s board of directors, Rostrum Medical has appointed Nathan Ayoubi to the position of Chief Operating Officer for Rostrum Medical, effective December 2021.

During and in the years following the formation of Rostrum Medical, Nathan’s focus has been on the technical development and clinical validation of the VQm® system, leading and carrying VQm® to its successful regulatory certifications, and overseeing the operational functions of Rostrum Medical. Nathan has been closely involved with the Medical Advisory Board and works closely with a team of international clinicians.

“Nathan showed consistency in his efforts and contribution to team building, growth in clinical knowledge and multi-discipline experience and leadership. He has also developed a good and respectful working relationship with our medical advisors to advance he clinical process for Rostrum’s mission to grow. Nathan has and continues to be a committed innovator during the early and latter phases of development for the VQm® and VQm Pulmonary Health Monitor (PHM™). We congratulate Nathan on this important achievement and shall look forward to his continued efforts and dedication as we stream toward commercialisation and growth.” says Awni Ayoubi, President/ CEO of Rostrum Medical Innovations.

“I am honored to take on this role to help lead the organization into this exciting next phase of development and commercialization of the VQm Pulmonary Health Monitor™. The VQm PHM™ is a game changing technology that we believe will have a fundamental positive impact on the care of mechanically ventilated patients, and I am excited to work alongside and contribute to a great and passionate team.”

Rostrum is looking forward to Nathan’s continued leadership as Rostrum launches VQm® into the global marketplace.

About Rostrum Medical

Rostrum Medical is dedicated to empowering medical professionals with innovative solutions to complex clinical challenges. With a team of some of the world’s most progressive clinicians, combined with engineering and business expertise with a history of commercial success, Rostrum is driven by one mission – to address clinical needs in healthcare.

About VQm® Pulmonary Health Monitor™

The VQm Pulmonary Health Monitor™ is a novel monitoring device that aims to provide clinicians with near real-time physiological insight into the effects of changes in lung mechanics of Mechanically Ventilated patients. The VQm PHM™ is being developed with the intention to assist physicians in their management of mechanical ventilation by providing measurements of the following physiological parameters: Shunt Index (Qsi), Dead space (VD), Pulmonary Blood Flow (PBF), and Functional Residual Capacity (FRC).

For more information or inquiries, please email: media@rostrummedical.com

Previous
Previous

Rostrum Medical Innovation Receives Health Canada Clearance for its 2nd Generation VQm Pulmonary Health Monitor™

Next
Next

New Study Confirms Agreement of Pulmonary Blood Flow Measurements between VQm PHM™ and Current Clinical Gold Standard.